# Bristol-Myers posts Q1 beat thanks to growth portfolio.

*business · news · 2026-04-30 · Seeking Alpha*

## Key points

- Bristol-Myers Squibb reported better-than-expected Q1 2026 financials.
- Growth portfolio performance offset declining demand for legacy products.
- The company recorded $11.5 billion in revenue for the quarter.
- BMY shares traded higher in premarket following the earnings report.

**Companies:** Bristol-Myers Squibb
**Countries:** United States

[Read the full story on Seeking Alpha](https://seekingalpha.com/news/4582718-bristol-myers-stock-focus-q1-2026-beat)

---

Canonical: https://newsio.io/n/0f3a9ec2-2f5a-4efe-9f10-3c5425455611/bristol-myers-posts-q1-beat-thanks-to-growth-portfolio-the-company-recorded-11-5
Summarized by Newsio from Seeking Alpha. https://newsio.io/how-it-works